Physician profile
Robert P Dolan
NPI 1558396614
$4,007.48
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $930 · 2021: $1,080 · 2022: $744 · 2023: $32.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,629.85 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $575.33 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $561.43 | 2019-2022 | |
| Janssen Biotech, INC. | $274.66 | 2019-2022 | |
| Pfizer INC. | $131.84 | 2019-2020 | |
| Celgene Corporation | $125.44 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $122.00 | 2019-2022 | |
| Ucb, INC. | $117.47 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $81.00 | 2021-2022 | |
| Qol Medical, LLC | $78.38 | 2019-2021 | |
| Shionogi INC | $46.45 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.13 | 2019-2020 | |
| Boston Scientific Corporation | $32.73 | 2023 | Compliance Bronchkit |
| Ironwood Pharmaceuticals, INC | $29.25 | 2020-2021 | |
| Allergan, INC. | $28.49 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $27.80 | 2022 | |
| Braintree Laboratories, INC. | $19.15 | 2020 | |
| Amgen INC. | $17.32 | 2022 | |
| Alfasigma USA, INC. | $16.55 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.33 | 2022 | |
| Daiichi Sankyo INC. | $13.22 | 2019 | |
| Redhill Biopharma INC. | $13.17 | 2021 | |
| Shire North American Group INC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.